Literature DB >> 34728089

Classical and noncanonical functions of miRNAs in cancers.

Mihnea P Dragomir1, Erik Knutsen2, George A Calin3.   

Abstract

Alterations in microRNAs (miRNAs) expression are causative in the initiation and progression of human cancers. The molecular events responsible for the widespread differential expression of miRNAs in malignancy are exemplified by their location in cancer-associated genomic regions, epigenetic mechanisms, transcriptional dysregulation, chemical modifications and editing, and alterations in miRNA biogenesis proteins. The classical miRNA function is synonymous with post-transcriptional repression of target protein genes. However, several studies have reported miRNAs functioning outside this paradigm and some of these novel modes of regulation of gene expression have been implicated in cancers. Here, we summarize key aspects of miRNA involvement in cancer, with a special focus on these lesser-studied mechanisms of action.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; germline and somatic mutations; miRNA; miRNA mimicry; non-canonical functions; pri- and pre-miRNA regulation

Mesh:

Substances:

Year:  2021        PMID: 34728089     DOI: 10.1016/j.tig.2021.10.002

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  18 in total

Review 1.  Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Rosa Drago-Ferrante; Yashwanth Subbannayya; Francesca Pentimalli; Antonio Giordano; Jean Calleja-Agius
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  CircPIK3C2A Facilitates the Progression of Glioblastoma via Targeting miR-877-5p/FOXM1 Axis.

Authors:  Jian Yang; Shuaiwei Tian; Baocheng Wang; Jiajia Wang; Liangliang Cao; Qinhua Wang; Wanqun Xie; Zhuangzhuang Liang; Heng Zhao; Yang Zhao; Keman Liao; Jie Ma
Journal:  Front Oncol       Date:  2021-12-24       Impact factor: 6.244

3.  Radix ranunculus temate saponins sensitizes ovarian cancer to Taxol via upregulation of miR-let-7b.

Authors:  Keli You; Yuejun Liu; Le Chen; Haiyan Ye; Wumei Lin
Journal:  Exp Ther Med       Date:  2022-03-04       Impact factor: 2.447

4.  MiR-182-5p Modulates Prostate Cancer Aggressive Phenotypes by Targeting EMT Associated Pathways.

Authors:  Marilesia Ferreira Souza; Ilce Mara Syllos Cólus; Aline Simoneti Fonseca; Valquíria Casanova Antunes; Deepak Kumar; Luciane Regina Cavalli
Journal:  Biomolecules       Date:  2022-01-22

5.  Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancer.

Authors:  Tudor Moisoiu; Mihnea P Dragomir; Stefania D Iancu; Simon Schallenberg; Giovanni Birolo; Giulio Ferrero; Dan Burghelea; Andrei Stefancu; Ramona G Cozan; Emilia Licarete; Alessandra Allione; Giuseppe Matullo; Gheorghita Iacob; Zoltán Bálint; Radu I Badea; Alessio Naccarati; David Horst; Barbara Pardini; Nicolae Leopold; Florin Elec
Journal:  Mol Med       Date:  2022-04-01       Impact factor: 6.354

Review 6.  The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers.

Authors:  Ilaria Cavallari; Francesco Ciccarese; Evgeniya Sharova; Loredana Urso; Vittoria Raimondi; Micol Silic-Benussi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

Review 7.  Targeting non-coding RNAs to overcome cancer therapy resistance.

Authors:  BaoQing Chen; Mihnea P Dragomir; Chen Yang; Qiaoqiao Li; David Horst; George A Calin
Journal:  Signal Transduct Target Ther       Date:  2022-04-13

Review 8.  Elucidating miRNA Function in Cancer Biology via the Molecular Genetics' Toolbox.

Authors:  Adam Azlan; Yaashini Rajasegaran; Khor Kang Zi; Aliaa Arina Rosli; Mot Yee Yik; Narazah Mohd Yusoff; Olaf Heidenreich; Emmanuel Jairaj Moses
Journal:  Biomedicines       Date:  2022-04-15

9.  MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype.

Authors:  Bruna M Sugita; Yara Rodriguez; Aline S Fonseca; Emanuelle Nunes Souza; Bhaskar Kallakury; Iglenir J Cavalli; Enilze M S F Ribeiro; Ritu Aneja; Luciane R Cavalli
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.639

Review 10.  The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation.

Authors:  Chiara Siniscalchi; Armando Di Palo; Aniello Russo; Nicoletta Potenza
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.